Discover how this AI blockchain token presale offers up to 1000× potential before DEX listing. Join early, note risks, act wisely.Discover how this AI blockchain token presale offers up to 1000× potential before DEX listing. Join early, note risks, act wisely.

IPO Genie Presale Offers 1000× Potential Before DEX Listing

5 min read
bull main

What if the biggest upside in crypto right now is still untapped?

What if one presale today could turn into a 1000× gain by the time of its DEX listing? In 2025, the ai blockchain token sector alone has surpassed $28 billion in market cap.

Enter IPO Genie ($IPO), currently priced at $0.0001 and ready to grant access to tokenised private-market deals and AI-driven insight. Meanwhile, dozens of projects claim a place in the “top ai crypto presales of 2025race. 

The big question: why should smart investors bet on IPO Genie now, and how real is that 1000× potential?

Why 2025 Is the Perfect Launchpad for This ai blockchain token

Investors are zeroing in on the concept of AI merging with blockchain. According to recent reports, the crypto + AI space is gaining mainstream institutional backing. Also, AI-linked tokens surged in market value by billions in just weeks. 

So, this environment gives projects like IPO Genie a timely platform. Because when an ai blockchain token arrives with utility, community, and pricing edge, early entry could yield outsized gains.

What Makes IPO Genie Unique

Here’s what differentiates IPO Genie from typical presales:

  • It offers tokenised access to private-market deals, which is rare in crypto presales.
  • It uses AI-driven deal-discovery for startups and pre-IPO firms (yes, that means real economy exposure).
  • The current presale price stands at $0.0001 per $IPO, making early entry a low barrier.
    Others might promise “AI” or “blockchain,” but few blend private-market exposure + token model + early stage pricing like this one.

Milestones & Momentum You Shouldn’t Ignore

This isn’t just hype. IPO Genie reports:

  • Multiple presale phases sold out fast.
  • A growing community of token holders (over thousands+ of wallets engaged).
  • A reward program raised, e.g., an airdrop boosted to $50,000 with 40 winners.
IPO
  • Plan for DEX listing soon, which could trigger listing liquidity and a price jump.
    The scarcity and momentum create FOMO: the longer you wait, the higher the entry price may go.

Snapshot of Presale Metrics & Upside Potential

MetricValue
Current Presale Price$0.0001 per $IPO
Targeted Upside Before DEXUp to 1000×
Community Walletsthousands+ (reported holders)
Airdrop/Rewards$50,000 allocation to winners
Next Major MilestoneDEX Listing (planned Q4 2025)

Thus, this gives a concrete view of what’s on the table and why the claim of “1000× potential” isn’t empty marketing, although nothing is guaranteed either.

What to Watch & Risk Factors

Every high-potential presale carries risk. For IPO Genie players should keep in mind:

  • Liquidity after DEX listing matters; without it, the token could stagnate.
  • Execution of tokenised private-market deal flow must happen. Promises must become real.
  • Regulatory shifts could impact “private-market token access” models.

Thus, this is not a guaranteed 1000×, but when a presale checks many boxes (utility, timing, low entry price), the potential is there.

Why It’s Being Tagged Among the Top ai crypto presales of 2025

Analyst reports of early-stage AI-blockchain tokens show that investor interest is strong. IPO Genie matches the profile: a token positioned within the ai blockchain token category, low early price, explicit roadmap, and presale phases. 

As a result, it is being discussed in the context of “top AI crypto presales of 2025.” If you believe the narrative of AI + blockchain growth, this could be one of the premium early plays.

How to Participate & What Early Entry Means

Here’s how someone might join:

  • Visit the official presale portal for IPO Genie $IPO.
  • Set up a compatible wallet, and follow the KYC or verification if required.
  • Buy $IPO at the current price of $0.0001 while the phase is active.
  • Hold until DEX listing and beyond (if comfortable).

By entering early, investors lock in the lowest entry price before listing, that is where the 1000× potential emerges (if the trajectory holds).

Final Takeaway

In the crowded world of AI blockchain token launches, IPO Genie ($IPO) stands out. With a low entry price, a utility-driven model, strong community momentum, and planned listing, the upside is impressive, up to 1000× before DEX listing. 

Yet the smart investor also acknowledges the risks, but with the highest potential rewards. So, this isn’t a sure bet, but for those willing to act early, the reward/risk profile looks compelling.

Now is the moment: the presale window is open and time is limited. If the trend holds, participants who join now could look back and say they entered when the token was still at $0.0001. 

So, grab this chance now before it DEX listing, because IPO Genie $IPO presale is still live and you still qualify. Also, $IPO airdrop is live for you, so join it now and become one of the luckiest people who will make $$$ without doing hard work.

ipogenie
  • Visit the official IPO Genie presale site and review the full tokenomics.
  • Join the community channels like Telegram and Twitter to stay informed about announcements and phase updates.
ipo
  • Evaluate personal allocation size, only invest what you are willing to risk.
  • Monitor the upcoming DEX listing date, as that will shift the dynamics sharply.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrencies are volatile and high-risk. Always perform your own research before investing.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29